Publication of prospectus with respect to Aerocrine´s new share issue 2008

The board of directors of Aerocrine AB has prepared a prospectus with respect to a share issue with preferential rights for the company´s shareholders. The prospectus is available on www.aerocrine.com or www.avanza.se (ongoing projects).

The prospectus is also available free of charge from Aerocrine AB, Sundbybergsvägen 9, Box 1024, SE-171 73 Solna, Sweden, as well as from Avanza Bank AB, Klarabergsgatan 60, Box 1399, SE-111 93 Stockholm, Sweden. Shareholders who are directly registered as holders of the Aerocrine share as at November 13 will receive the prospectus by mail.

Solna November 12 2008
Aerocrine AB (publ)

For further information contact:

Paul de Potocki, CEO, telephone: +46 8 629 07 82
---------------------------

This press release may not be announced, published or disseminated, directly or indirectly, in the United States of America, Canada, Australia, Hong Kong, Japan or in any other country where such measure wholly or partly is subject to restrictions by law.

The information in this press release may not be forwarded, reproduced or shown in way that is in conflict with such restrictions. Failure to comply with this instruction may constitute a crime according the United States Securities Act of 1933 ("Securities Act") or applicable laws in other jurisdictions.

Nothing in this press release shall be deemed to constitute and offer to invest, subscribe or otherwise deal with shares, subscription right or other securities of Aerocrine.

Neither the subscription right, nor the paid and subscribed shares or the new shares will be registered according the Securities Act or any provincial law in Canada and may not be transferred or offered for sale in the USA or Canada, or to a person domiciled in such state or for such persons account other in excepted cases, where registration is not required according the Securities act or any provincial law in Canada.
---------------------------